Home » FDA Extends Comment Period for Guidance on Quality Metrics Submissions
FDA Extends Comment Period for Guidance on Quality Metrics Submissions
The FDA is extending the comment period for a guidance document on the submission of quality metrics data to March 27.
The agency released the guidance on Nov. 25 with a 60-day comment period. The extension will not significantly delay finalization of the guidance.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May